MBOT
Microbot Medical Inc.
$3.31
+$0.12(+3.76%)
45
Overall
--
Value
45
Tech
--
Quality
Market Cap
$152.12M
Volume
3.84M
52W Range
$0.85 - $4.67
Target Price
$12.00
Order:
Income Statement
| Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $116.9K | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Total Revenue | $116.9K | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | -- | -- | -- | -- | -- | $3.8M | $3.9M | $4.6M | -- | -- | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $116.9K | -- | -- | -- | -- | $-3.8M | $-3.9M | $-4.6M | -- | -- | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $-915.0K | $-9.6M | $5.3M | $7.2M | $7.2M | $9.1M | $11.4M | $13.4M | $9.9M | $11.6M | ||
| Research & Development | $-823.0K | $-901.0K | $1.1M | $2.5M | $3.0M | $3.4M | $6.2M | $7.7M | $5.7M | $6.6M | ||
| Research Expense | $-823.0K | $-901.0K | $1.1M | $2.5M | $3.0M | $3.4M | $6.2M | $7.7M | $5.7M | $6.6M | ||
| Selling, General & Administrative | $-92.0K | $-8.7M | $4.2M | $4.7M | $4.2M | $5.7M | $5.2M | $5.5M | $4.1M | $5.0M | ||
| General & Administrative Expenses | $-92.0K | $-8.7M | $4.2M | $4.7M | $4.2M | $5.7M | $5.2M | $5.5M | $4.1M | $5.0M | ||
| Salaries & Wages | $-186.0K | $-676.0K | $-479.0K | $-1.4M | $-1.1M | $1.9M | $1.9M | $1.8M | $1.4M | $1.3M | ||
| Depreciation & Amortization | $-17.0K | $-10.0K | $-21.0K | $-54.0K | -- | -- | -- | -- | -- | -- | ||
| Depreciation & Amortization | $-17.0K | $-10.0K | $-21.0K | $-54.0K | -- | -- | -- | -- | -- | -- | ||
| Amortization | $-72.0K | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Other Operating Expenses | $392.2K | -- | -- | -- | -- | -- | -- | -- | -- | $239.0K | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $915.0K | $9.6M | $-5.3M | $-7.2M | $-7.2M | $-9.1M | $-11.4M | $-13.3M | $-9.9M | $-11.6M | ||
| EBITDA | $920.0K | $9.3M | $-3.2M | $-7.2M | $-7.3M | $-9.0M | $-11.3M | $-13.3M | $-10.6M | $-11.4M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $-6.0K | $-333.0K | $-237.0K | -- | -- | $80.0K | -- | -- | -- | -- | ||
| Intinc | $7.5K | -- | $2.3M | $-16.0K | $-103.0K | $-80.0K | $44.0K | $118.0K | $228.0K | $182.0K | ||
| Net Non-Operating Interest Income/Expense | $-6.0K | $28.0K | $2.3M | $-16.0K | $-103.0K | $-80.0K | $44.0K | $-54.0K | $228.0K | $182.0K | ||
| Other Income/Expense | $-804.2K | $262.0K | $2.4M | $20.0K | -- | -- | -- | $215.0K | $2.0K | $1.2M | ||
| Other Special Charges | $1.0M | $-262.0K | $-2.4M | $-20.0K | -- | -- | -- | $-5.0K | $-1.2K | $-1.2M | ||
| SPECIAL ITEMS | ||||||||||||
| Special Income Charges | $239.2K | -- | -- | -- | -- | -- | -- | -- | $-1.1M | -- | ||
| Impairment of Capital Assets | $-239.2K | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $903.0K | $9.3M | $-3.2M | $-7.3M | $-7.3M | $-9.1M | $-11.4M | $-13.4M | $-10.7M | $-11.4M | ||
| Pre-Tax Income | $909.0K | $9.7M | $-2.9M | $-7.3M | $-7.3M | $-9.2M | $-11.3M | $-13.2M | $-10.7M | $-11.4M | ||
| NET INCOME | ||||||||||||
| Net Income | $909.0K | $9.7M | $-2.9M | $-7.3M | $-7.2M | $-9.2M | $-11.3M | $-13.2M | $-10.7M | $-11.4M | ||
| Net Income (Continuing Operations) | $909.0K | $9.7M | $-2.9M | $-7.3M | $-7.2M | $-9.2M | $-11.3M | $-13.2M | $-10.7M | $-11.4M | ||
| Net Income (Discontinued Operations) | $909.0K | $9.7M | $-2.9M | $-7.3M | $-7.2M | $-9.2M | $-11.3M | $-13.2M | $-10.7M | $-11.4M | ||
| Net Income (Common Stockholders) | $909.0K | $9.7M | $-2.9M | $-7.3M | $-7.2M | $-9.2M | $-11.3M | $-13.2M | $-10.7M | $-11.4M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | $-8.9M | -- | -- | -- | ||
| TOTALS | ||||||||||||
| Total Expenses | $-915.0K | $-9.6M | $5.3M | $7.2M | $7.2M | $12.9M | $15.2M | $13.4M | $9.9M | $11.6M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $6.4M | $952.9K | $2.2M | $2.9M | $4.3M | $7.1M | $7.1M | $7.3M | $10.2M | $15.6M | ||
| Average Shares Outstanding (Diluted) | $6.4M | $1.6M | $2.8M | $3.0M | $4.3M | $7.1M | $7.1M | $7.3M | $10.2M | $15.6M | ||
| Shares Outstanding | $69.4K | $1.8M | $2.8M | $4.3M | $7.1M | $7.1M | $7.1M | $8.1M | $14.4M | $34.7M | ||
| Basic EPS | -- | -- | -- | -- | -- | -- | -- | $-1.81 | $-1.05 | $-0.73 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | -- | -- | -- | -- | $-1.81 | $-1.05 | $-0.73 | ||
| Diluted EPS | $-5.7 | $6 | $2.7 | $-2.41 | $-1.7 | $-1.29 | $-1.59 | $-1.81 | $-1.05 | $-0.73 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | $-1.7 | $-1.29 | $-1.59 | -- | $-1.05 | $-0.73 | ||
| OTHER METRICS | ||||||||||||
| Gain On Sale Of P P E | -- | -- | -- | -- | -- | -- | -- | $-5.0K | $-2.0K | -- | ||
| Net Income From Other Gains Losses | -- | -- | -- | -- | $96.0K | -- | -- | -- | -- | -- | ||
| Net Operating Interest Income Expense | -- | -- | $1.0K | $2.0K | -- | -- | -- | -- | -- | -- | ||
| Non Recurring Operation Expense | -- | -- | -- | -- | -- | -- | -- | -- | $1.1M | -- | ||
| Other Gand A | $-92.0K | $-8.7M | $4.2M | $4.7M | $4.2M | $5.7M | $5.2M | $5.5M | $4.1M | $5.0M | ||
| Other Impairment Of Capital Assets | $239.2K | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Otherunder Preferred Stock Dividend | $360.0K | $-4.0M | $-1.6M | $-254.0K | -- | -- | -- | -- | -- | -- | ||
| Preferred Stock Dividends | $360.0K | $-4.0M | $-1.6M | $-254.0K | -- | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $-92.0K | $-8.7M | $4.2M | $4.7M | -- | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MBOT | $3.31 | +3.8% | 3.84M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |